Paper Details
- Home
- Paper Details
Original Abstract of the Article :
138 patients, suffering from rheumatoid arthritis, were treated with sulfasalazine for up to 43 months. In 58.7% of the patients a good or moderate effect was ascertained. Side-effects occurred in 40.5% of the treated patients, mostly in the first 4 months after starting treatment, but some of the m...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/1970208
データ提供:米国国立医学図書館(NLM)
Sulfasalazine for Chronic Polyarthritis: A Comprehensive Look
Chronic polyarthritis, a condition characterized by persistent joint inflammation, is a formidable foe. This study investigated the effectiveness and safety of sulfasalazine, a medication commonly used to treat inflammatory bowel disease, in treating rheumatoid arthritis, a type of chronic polyarthritis. The study aimed to assess the drug's efficacy and profile potential side effects, providing insights into its therapeutic potential.
Sulfasalazine: A Promising but Complex Treatment
The study found that sulfasalazine demonstrated a moderate to good effect in nearly 60% of patients with rheumatoid arthritis. However, it also highlighted the importance of closely monitoring patients for side effects. While most side effects occurred early in treatment, some serious adverse reactions emerged later. The study emphasizes the need for regular laboratory tests to ensure patient safety and monitor for potential drug-related complications.
Managing Side Effects: A Collaborative Approach
The study underscores the need for a cautious approach to using sulfasalazine for rheumatoid arthritis. Close monitoring of laboratory parameters, such as liver enzymes, kidney function, and blood cell counts, is crucial. Patients should be aware of potential side effects and work closely with their healthcare provider to manage any complications.
Dr.Camel's Conclusion
The study offers a comprehensive view of sulfasalazine's potential benefits and risks in the treatment of rheumatoid arthritis. While the drug demonstrates promise, it requires careful monitoring and personalized management to ensure optimal outcomes and mitigate potential side effects. Just as a desert traveler needs to be vigilant about hydration and prepare for unexpected challenges, individuals taking sulfasalazine should be aware of the potential risks and work closely with their healthcare provider to navigate their treatment journey.
Date :
- Date Completed 1990-05-21
- Date Revised 2013-11-21
Related Literature
German
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.